Quick summary: Panhematin powder for solution: Sterility concern. Date: 2024-09-13.
Public recall detail
Panhematin powder for solution: Sterility concern
2024-09-13
Recall
Safety notice
Quick summary
Recommended action
Recommended action: compare your product with the official notice and follow the instructions published by the official source.
Recall details
Quick summary: Panhematin powder for solution: Sterility concern. Date: 2024-09-13.
Official details
Affected product details
Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.
BrandRecordati Rare Diseases Canada
ProductPanhematin 268 mg/vial powder for solution
IssueHealth products - Product quality
Recall classType I
IdentificationRA-76042
Affected products
BrandRecordati Rare Diseases Canada
ProductPanhematin powder for solution
DIN / NPN / authorizationDIN 02478765
Dosage formPowder for Solution
StrengthHemin 268 mg/vial
Lot485407C
Issue
Product sterility may be compromised in affected lot.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional official information
AudienceHealthcare Hospitals
CategoryHealth products - Biologic or vaccine
CompaniesRecalling firm: Recordati Rare Diseases Canada (care of McKesson Specialized Distribution) 8449 Lawson Rd, Unit 102 Milton, Ontario L9T 9L1 Canada Market authorization holder: Recordati Rare Diseases Canada Inc. 3080 Yonge Street, Suite 6060 Toronto, Ontario, M4N 3N1 Canada
Published byHealth Canada
Recall classType I
Alert / recall typeHealth product recall
Identification numberRA-76042
Background{}
CompaniesRecalling firm: Recordati Rare Diseases Canada (care of McKesson Specialized Distribution) 8449 Lawson Rd, Unit 102 Milton, Ontario L9T 9L1 Canada Market authorization holder: Recordati Rare Diseases Canada Inc. 3080 Yonge Street, Suite 6060 Toronto, Ontario, M4N 3N1 Canada
AudiencesHealthcare Hospitals
Source updated2024-09-13
Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.
FAQ
Frequently asked questions
Answers based on the official recall notice.
Product images
Official product images from Health Canada.
Starting...
Explore more
Related recalls
Similar recalls and safety notices.